logo

CURX

CuranexยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

CURX Profile

Curanex Pharmaceuticals Inc

A pharmaceutical company dedicated to developing plant-based drugs for the treatment of inflammatory diseases

Pharmaceutical
06/01/2018
08/26/2025
NASDAQ Stock Exchange
--
12-31
Common stock
2 Jericho Plaza, Suite 101B, Jericho, NY 11753
--
Curanex Pharmaceuticals Inc was originally incorporated in New York State on June 1, 2018 and later transformed into a Delaware corporation. Curanex is a development-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative plant medicines to treat patients with inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields such as autoimmune diseases, metabolic diseases and viral infections.